Pro-inflammatory immune pathways

Pro-inflammatory immune pathways encompass a diverse array of intracellular and extracellular signaling networks that mediate the body's inflammatory response to infection, injury, or stress [1]. These pathways, including the NF-κB, JAK-STAT, and MAPK cascades, are responsible for the production and regulation of various inflammatory mediators such as cytokines, chemokines, and enzymes [2]. While these processes are vital for host defense and tissue homeostasis, their chronic or excessive activation is a primary driver of many pathological conditions, including rheumatoid arthritis, inflammatory bowel disease, and systemic lupus erythematosus [3]. Pharmacological modulation of these pathways is a cornerstone of modern immunology, utilizing biologics to neutralize specific cytokines or small molecules to inhibit key signaling enzymes [4]. For example, TNF inhibitors and JAK inhibitors are widely used to treat autoimmune disorders by dampening these specific signaling cascades [4]. However, because these pathways are also essential for normal immune surveillance, therapeutic targeting carries risks such as increased susceptibility to infections and potential long-term safety issues [5]. Monitoring biomarkers like C-reactive protein and specific cytokine levels helps clinicians assess the activity of these pathways and the efficacy of treatment [5].

Other names

Inflammatory signaling pathwaysPro-inflammatory cascadesCytokine signaling pathways

Inhibition of pro-inflammatory cytokines, antagonism of cytokine receptors, and inhibition of intracellular signaling kinases such as Janus kinases (JAK) or IκB kinase (IKK) to prevent gene transcription of inflammatory mediators.